Recent advances in the management of variceal bleeding.

PubWeight™: 0.76‹?›

🔗 View Article (PMID 28533909)

Published in Gastroenterol Rep (Oxf) on April 07, 2017


Ihteshamul Haq1, Dhiraj Tripathi1

Author Affiliations

1: Liver Unit, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham, UK.

Articles cited by this

(truncated to the top 100)

Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med (2013) 10.19

Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med (2010) 8.40

Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. Hepatology (2010) 8.11

Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med (2005) 6.31

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet (1995) 6.06

Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. BMJ (1995) 5.98

Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol (2010) 5.78

The coagulopathy of chronic liver disease. N Engl J Med (2011) 5.63

Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol (2015) 4.91

Nonselective β blockers increase risk for hepatorenal syndrome and death in patients with cirrhosis and spontaneous bacterial peritonitis. Gastroenterology (2014) 4.36

Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology (1992) 4.22

Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology (2007) 4.09

Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. N Engl J Med (1988) 3.53

Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology (2007) 3.39

The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33

Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology (2009) 3.20

Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology (2003) 3.19

Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. J Hepatol (2008) 3.12

The treatment of portal hypertension: a meta-analytic review. Hepatology (1995) 3.11

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology (1990) 2.99

A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding. Endoscopy (2007) 2.78

Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology (2002) 2.49

Improved survival after variceal bleeding in patients with cirrhosis over the past two decades. Hepatology (2004) 2.49

Incidence and natural history of small esophageal varices in cirrhotic patients. J Hepatol (2003) 2.46

Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology (2006) 2.39

Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers. Am J Gastroenterol (2012) 2.30

Non-selective β-blockers are associated with improved survival in patients with ascites listed for liver transplantation. Gut (2014) 2.26

Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol (2009) 2.22

Urgent vs. non-urgent endoscopy in stable acute variceal bleeding. Am J Gastroenterol (2009) 2.17

Prevention of variceal rebleeding. Lancet (2003) 2.16

Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis (1999) 2.15

Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology (2014) 2.14

Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology (1998) 2.10

Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver. J Am Coll Surg (1995) 2.10

Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology (1985) 2.09

Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage, Based on Child-Pugh Class, and Effects of Antibiotics. Clin Gastroenterol Hepatol (2014) 2.05

Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med (1995) 2.04

The role of the transjugular intrahepatic portosystemic stent shunt (TIPSS) in the management of bleeding gastric varices: clinical and haemodynamic correlations. Gut (2002) 2.00

Risk factors for hemorrhage from gastric fundal varices. Hepatology (1997) 1.92

Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis (2001) 1.91

Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut (2012) 1.83

A MELD-based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology (2013) 1.77

Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology (1998) 1.74

Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers: a randomized controlled trial. J Hepatol (2010) 1.66

Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology (2003) 1.64

Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology (1999) 1.64

Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol (2005) 1.63

Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review. Aliment Pharmacol Ther (2011) 1.62

Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis. Hepatology (1999) 1.62

Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy. J Hepatol (2007) 1.60

Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. Gut (2008) 1.56

Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology (2004) 1.55

Acute variceal haemorrhage in the United Kingdom: patient characteristics, management and outcomes in a nationwide audit. Dig Liver Dis (2014) 1.49

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. Gastroenterology (2016) 1.48

A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis. Gastroenterology (2004) 1.47

Randomized controlled trial of emergency transjugular intrahepatic portosystemic shunt versus emergency portacaval shunt treatment of acute bleeding esophageal varices in cirrhosis. J Gastrointest Surg (2012) 1.45

Non invasive evaluation of portal hypertension using transient elastography. J Hepatol (2011) 1.42

Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci (1988) 1.40

Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol (2000) 1.39

Functional aspects on the pathophysiology of portal hypertension in cirrhosis. J Hepatol (2012) 1.34

Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis. Hepatology (2002) 1.30

Transjugular intrahepatic portosystemic shunts for patients with active variceal hemorrhage unresponsive to sclerotherapy. Gastroenterology (1996) 1.28

Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol (2012) 1.23

UK guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut (2015) 1.20

Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J Gastroenterol Hepatol (1999) 1.19

The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients: refining short-term prognosis and risk factors. Am J Gastroenterol (2012) 1.16

Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut (2010) 1.15

Esophageal tamponade for bleeding varices. Controlled trial between the Sengstaken-Blakemore tube and the Linton-Nachlas tube. Gastroenterology (1978) 1.13

Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults. Cochrane Database Syst Rev (2012) 1.05

Terlipressin for acute esophageal variceal hemorrhage. Cochrane Database Syst Rev (2003) 1.04

Emergency transjugular intrahepatic portasystemic stent shunting as salvage treatment for uncontrolled variceal bleeding. Br J Surg (1994) 1.02

The window hypothesis: haemodynamic and non-haemodynamic effects of β-blockers improve survival of patients with cirrhosis during a window in the disease. Gut (2012) 0.99

A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage. Hepatology (2008) 0.97

Predicting failure to control bleeding and mortality in acute variceal bleeding. J Hepatol (2007) 0.96

Review article: recent advances in the management of bleeding gastric varices. Aliment Pharmacol Ther (2006) 0.96

Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther (2012) 0.95

Comparison of transnasal small-caliber vs. peroral conventional esophagogastroduodenoscopy for evaluating varices in unsedated cirrhotic patients. Endoscopy (2011) 0.94

Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function. Gastroenterology (1989) 0.94

Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis. Gastroenterology (2015) 0.92

Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial. Hepatol Int (2012) 0.91

Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology (2016) 0.91

Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis. Aliment Pharmacol Ther (2014) 0.90

Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study. J Hepatol (2012) 0.90

Potential applications of thromboelastography in patients with acute and chronic liver disease. Gastroenterol Hepatol (N Y) (2012) 0.88

Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem. Clin Gastroenterol Hepatol (2015) 0.86

Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther (2014) 0.86

Isosorbide-5-mononitrate versus propranolol in the prevention of first bleeding in cirrhosis. Gastroenterology (1993) 0.86

Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial. J Hepatol (2013) 0.86

Meta-analysis: beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding. Ann Hepatol (2012) 0.85

Effect of recombinant Factor VIIa on outcome of acute variceal bleeding: an individual patient based meta-analysis of two controlled trials. J Hepatol (2014) 0.85

Case report: bleeding gastric varices secondary to splenic vein thrombosis successfully treated by splenic artery embolization. Br J Radiol (1995) 0.84

Drugs plus ligation to prevent rebleeding in cirrhosis: an updated systematic review. Liver Int (2014) 0.84

Flexible imaging color enhancement improves visibility of transnasal endoscopic images in diagnosing esophageal varices: a multicenter prospective blinded study. J Dig Dis (2012) 0.82

Esophageal balloon tamponade versus esophageal stent in controlling acute refractory variceal bleeding: A multicenter randomized, controlled trial. Hepatology (2016) 0.82

[Variceal hemorrhage in portal hypertension: role of surgery in the acute and elective situation]. Schweiz Med Wochenschr (1999) 0.81

Three months of simvastatin therapy vs. placebo for severe portal hypertension in cirrhosis: A randomized controlled trial. Dig Liver Dis (2015) 0.81

Isolated gastric varices resulting from iatrogenic splenic vein occlusion: report of a case. Surg Today (2003) 0.80

Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study. Hepatology (2016) 0.79

Portal hypertension ameliorates arterial hypertension in spontaneously hypertensive rats. J Hepatol (1989) 0.79

Salvage tips for uncontrolled variceal bleeding. J Hepatol (2002) 0.79